WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

KOSDAQ:330350 Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	102,494	102,722	80,119	64,680	57,419	53,406
Other Revenue	-0	-	-0	-	-	-0
Revenue	102,494	102,722	80,119	64,680	57,419	53,406
Revenue Growth (YoY)	4.29%	28.21%	23.87%	12.65%	7.51%	1.93%
Cost of Revenue	37,374	37,168	31,481	26,345	23,894	21,076
Gross Profit	65,120	65,554	48,638	38,335	33,525	32,330
Selling, General & Admin	56,255	56,002	37,237	29,767	26,100	22,699
Research & Development	1,600	2,297	1,868	2,357	1,420	1,807
Amortization of Goodwill & Intangibles	1,238	1,194	956.43	576.93	184.34	5.68
Other Operating Expenses	181.93	178.61	186.67	278.07	296.44	202.68
Operating Expenses	59,635	59,893	40,729	33,457	28,639	25,100
Operating Income	5,485	5,661	7,909	4,878	4,886	7,230
Interest Expense	-788.53	-814.08	-596.06	-390.74	-323.96	-229.23
Interest & Investment Income	499.7	486.88	727.19	468.62	392.66	464.09
Currency Exchange Gain (Loss)	1.68	-3.18	1.72	0.63	-3.98	6.57
Other Non Operating Income (Expenses)	509.2	147.77	-425.51	-435.03	-305.14	-235.98
EBT Excluding Unusual Items	5,707	5,478	7,617	4,521	4,646	7,236
Gain (Loss) on Sale of Investments	1,053	-133.97	1,515	-373.86	979.32	520.11
Gain (Loss) on Sale of Assets	-	-	9.04	10.78	-385	5.13
Asset Writedown	-205	-205	-	-	-	-
Pretax Income	6,554	5,139	9,141	4,158	5,240	7,761
Income Tax Expense	574.32	354.3	1,182	1,679	976.07	1,109
Net Income	5,980	4,785	7,959	2,479	4,264	6,652
Net Income to Common	5,980	4,785	7,959	2,479	4,264	6,652
Net Income Growth	-21.85%	-39.88%	221.04%	-41.86%	-35.91%	-17.24%
Shares Outstanding (Basic)	13	13	13	13	13	8
Shares Outstanding (Diluted)	13	13	13	13	13	8
Shares Change (YoY)	-0.39%	0.00%	0.09%	-0.10%	59.55%	6.63%
EPS (Basic)	453.69	362.49	603.00	188.00	323.00	804.02
EPS (Diluted)	453.69	362.49	603.00	188.00	323.00	804.02
EPS Growth	-21.54%	-39.89%	220.75%	-41.80%	-59.83%	-22.39%
Free Cash Flow	12,603	7,268	-12,044	-9,952	1,354	-4,455
Free Cash Flow Per Share	956.14	550.60	-912.45	-754.70	102.59	-538.39
Gross Margin	63.53%	63.82%	60.71%	59.27%	58.39%	60.54%
Operating Margin	5.35%	5.51%	9.87%	7.54%	8.51%	13.54%
Profit Margin	5.83%	4.66%	9.93%	3.83%	7.43%	12.46%
Free Cash Flow Margin	12.30%	7.07%	-15.03%	-15.39%	2.36%	-8.34%
EBITDA	9,438	9,438	10,754	6,826	6,387	9,207
EBITDA Margin	9.21%	9.19%	13.42%	10.55%	11.12%	17.24%
D&A For EBITDA	3,953	3,778	2,844	1,948	1,501	1,977
EBIT	5,485	5,661	7,909	4,878	4,886	7,230
EBIT Margin	5.35%	5.51%	9.87%	7.54%	8.51%	13.54%
Effective Tax Rate	8.76%	6.89%	12.93%	40.38%	18.63%	14.29%
Advertising Expenses	-	832.52	841.87	831.45	887	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.